AstraZeneca to invest nearly 200 million yuan in Wuxi drug facility
AI Summary- AstraZeneca will upgrade its Wuxi development and supply building for a cardiovascular drug.
- The project covers 5,800 square meters and targets 400 million tablets annually.
- Operations are scheduled to begin in the fourth quarter of 2029.